4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-068456
Chief Executive Officer gave up 37,818 shares (to pay taxes)
- Chief Executive Officer acquired 80,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-12-03 | Option exercise | +80,000 | 299,153 | D: show line 1 in the form | ||
| Kulkarni Samarth Chief Executive Officer | 2021-12-06 | Shares withheld for taxes | −37,818 | $69.17 | $2,615,871 | 261,335 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-12-03 | Option exercise · Restricted Stock Units | +80,000 | 40,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…